Business Context and Reporting Period
This Form 8-K filing by BIO-RAD LABORATORIES, INC. reports on the results of the Annual Meeting of Stockholders held on April 26, 2016. The filing details the outcomes of votes regarding director elections, auditor ratification, and a stockholder proposal.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The filing reports the following material outcomes from the stockholder vote:
- Director Elections: All nominated directors were elected by a majority of votes cast.
- Class A Directors: Louis Drapeau and Robert M. Malchione received significant affirmative support (approx. 18 million votes each) with minimal opposition.
- Class B Directors: Joel McComb, Deborah J. Neff, Alice N. Schwartz, and Norman Schwartz were elected with overwhelming support (approx. 4.9 million votes each).
- Auditor Ratification: The proposal to ratify KPMG LLP as the independent auditor for the fiscal year ending December 31, 2016, was approved with 7,232,752 votes for and 1,061 votes against.
- Stockholder Proposal: A proposal regarding shareholder proxy access was not approved. It received 1,360,744 votes for and 5,474,487 votes against.
Guidance, Outlook, and Risks
The filing text does not provide any management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly limited to the reporting of voting results.
Key Facts for Investor Verification
- Verify the re-election of the full slate of directors, noting the high approval rates across both Class A and Class B stock.
- Confirm the ratification of KPMG LLP as the independent auditor for the 2016 fiscal year.
- Note the significant rejection of the shareholder proxy access proposal, indicating strong opposition from the voting base.
- Recognize that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial metrics.